The Medicines Company (NASDAQ:MDCO) – Equities researchers at Leerink Swann increased their Q2 2017 earnings per share (EPS) estimates for shares of The Medicines Company in a report released on Wednesday. Leerink Swann analyst J. Schwartz now expects …
The post Leerink Swann Equities Analysts Raise Earnings Estimates for The Medicines Company (MDCO) appeared first on ForexTV.
April 30, 2017 at 03:01PM
from Equities News Editor
No comments:
Post a Comment